Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC compounds

2021/42/E/NZ5/00227

Keywords

Descriptors

  • NZ5_003: Patogeneza chorób człowieka
  • NZ3_007: Przekaźnictwo sygnału

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Anna Agnieszka Marusiak

Number of co-investigators in the project: 5

Call

SONATA BIS 11 – announced on 2021-06-15

Amount awarded
4 035 160 PLN
Project start date
2022-03-24
Project end date
2027-03-23
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (3)

  1. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.

    Authors:
    Torres-Ayuso, P., Katerji, M., Mehlich, D., Lookingbill, S. A., Sabbasani, V. R., Liou, H., Casillas, A. L., Chauhan, S. S., Serwa, R., Rubin, M. R., Marusiak, A. A., Swenson, R. E., Warfel, N. A., Brognard, J
    Academic press:
    Cell Chemical Biology (year: 2024, volume: 31, pages: 46034), Publisher: Elsevier Ltd
    Status:
    Published
    DOI:
    10.1016/j.chembiol.2023.10.023 – link to the publication
  2. Drivers of cancer metastasis - Arise early and remain present

    Authors:
    Dagmara Dymerska, Anna Marusiak
    Academic press:
    BBA Reviews on Cancer (year: 2023, volume: 1879, pages: 189060), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bbcan.2023.189060 – link to the publication
  3. Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC

    Authors:
    Kamila Karpińska,# Dawid Mehlich,# Venkata R. Sabbasani, Michał Łomiak, Pedro Torres-Ayuso, Katarzyna Wróbel, Vi Nguyen-Phuong Truong, Remigiusz Serwa, Rolf E. Swenson, John Brognard,* and Anna A. Marusiak*
    Academic press:
    Journal of Medicinal Chemistry (year: 2024, volume: 67/17, pages: 15012–15028), Publisher: American Chemical Society.
    Status:
    Published
    DOI:
    10.1021/acs.jmedchem.4c00577 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski